Abstract |
Choroidal neovascular membranes are a rare cause of decreased vision in children with congenital choroidal and optic nerve colobomas. We report on the regression of coloboma-related choroidal neovascular membranes in 2 children treated with intravitreal bevacizumab. Visual acuity remained improved in both children 2 years after the last injection.
|
Authors | Prashant Naithani, Naginder Vashisht, Subrata Mandal, Preeti Sankaran, Satpal Garg |
Journal | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
(J AAPOS)
Vol. 14
Issue 3
Pg. 288-90
(Jun 2010)
ISSN: 1528-3933 [Electronic] United States |
PMID | 20603066
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Bevacizumab
|
Topics |
- Angiogenesis Inhibitors
(administration & dosage)
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Child
- Child, Preschool
- Choroidal Neovascularization
(complications, congenital, drug therapy)
- Coloboma
(complications)
- Female
- Humans
- Injections, Intraocular
- Optic Nerve
(abnormalities)
- Treatment Outcome
- Visual Acuity
(drug effects)
|